Judge Blocks RFK Jr. Vaccine Policy Overhaul
SkimNews Take
With courts now serving as gatekeeper, the halted vaccine policy overhaul must clear judicial review before any provision takes effect—resetting the reform timeline to the courts' pace rather than HHS's.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Judge Brian E. Murphy issued a 45-page preliminary ruling in Boston finding that Kennedy's reconstitution of the Advisory Committee on Immunization Practices (ACIP) and January changes to the childhood vaccine schedule likely violated the Administrative Procedure Act.
- ACIP's scheduled Wednesday and Thursday meeting was postponed after the court blocked any votes by the committee as currently constituted; the judge found "no evidence in the record" that new members have "any relevant vaccine-related experience or expertise."
- Kennedy fired the entire previous slate of ACIP members last June, and Murphy criticized the "lack of formality and process" in the remake, noting that adding new members previously took two years and broad candidate outreach.
- 28 states have already altered their guidance to no longer follow HHS or ACIP recommendations, raising longer-term questions about how the panel can rebuild trust with professional societies and states.
- HHS spokesperson Andrew Nixon said the department "looks forward to this judge's decision being overturned just like his other attempts to keep the Trump administration from governing," and the government is expected to appeal.
- The ruling does not cover all of the administration's vaccine policy changes — federal research funding and FDA approvals for new shots are not directly implicated.
- The White House has increasingly weighed the political risk of a vaccine-heavy agenda in an election year, with Northeastern law professor Wendy Parmet noting "there seems to be some reluctance" from the administration on focusing too heavily on the issue.
Why it matters: The ruling freezes a signature Kennedy initiative in a major election year and creates an awkward bind for the administration: appealing to the Supreme Court would require arguing the committee changes carry enough legal weight to be reviewable, even though the government has previously claimed they were merely recommendations. With 28 states already breaking from federal vaccine guidance, the court's finding that the panel lacks qualified expertise deepens — rather than resolves — the credibility crisis around ACIP.
